Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 15;20(6):1305.
doi: 10.3390/ijms20061305.

The Therapeutic Potential of Apigenin

Affiliations
Review

The Therapeutic Potential of Apigenin

Bahare Salehi et al. Int J Mol Sci. .

Abstract

Several plant bioactive compounds have exhibited functional activities that suggest they could play a remarkable role in preventing a wide range of chronic diseases. The largest group of naturally-occurring polyphenols are the flavonoids, including apigenin. The present work is an updated overview of apigenin, focusing on its health-promoting effects/therapeutic functions and, in particular, results of in vivo research. In addition to an introduction to its chemistry, nutraceutical features have also been described. The main key findings from in vivo research, including animal models and human studies, are summarized. The beneficial indications are reported and discussed in detail, including effects in diabetes, amnesia and Alzheimer's disease, depression and insomnia, cancer, etc. Finally, data on flavonoids from the main public databases are gathered to highlight the apigenin's key role in dietary assessment and in the evaluation of a formulated diet, to determine exposure and to investigate its health effects in vivo.

Keywords: apigenin; cancer; chronic diseases; diabetes; flavonoids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Basic structure of the flavane, isoflavane, and neoflavane backbones, flavanone (2,3-dihydro-2-phenylchroman-4-one) and of the various classes of flavonoids.
Figure 2
Figure 2
Structures of apigenin and its glycosidic, glucuronide, acetylated, and methyl ester derivatives together with some biflavonoids of apigenin.
Figure 3
Figure 3
Biogenetic pathway of apigenin biosynthesis.
Figure 4
Figure 4
(A) Animal model studies involving apigenin effects in diabetes and cancer [82,83,84,85,86,87,88,89,90,91]. (B) Animal model studies involving apigenin effects in Alzheimer’ disease and amnesia [92,93,94,95,96,97]. (C). Animal model studies involving apigenin effects in depression [98,99,100,101].
Figure 4
Figure 4
(A) Animal model studies involving apigenin effects in diabetes and cancer [82,83,84,85,86,87,88,89,90,91]. (B) Animal model studies involving apigenin effects in Alzheimer’ disease and amnesia [92,93,94,95,96,97]. (C). Animal model studies involving apigenin effects in depression [98,99,100,101].
Figure 4
Figure 4
(A) Animal model studies involving apigenin effects in diabetes and cancer [82,83,84,85,86,87,88,89,90,91]. (B) Animal model studies involving apigenin effects in Alzheimer’ disease and amnesia [92,93,94,95,96,97]. (C). Animal model studies involving apigenin effects in depression [98,99,100,101].
Figure 5
Figure 5
Human studies monitoring apigenin supplementation [102,103,104,105,106].

References

    1. Amarowicz R., Carle R., Dongowski G., Durazzo A., Galensa R., Kammerer D., Maiani G., Piskula M.K. Influence of postharvest processing and storage on the content of phenolic acids and flavonoids in foods. Mol. Nutr. Food Res. 2009;53:S151–S183. doi: 10.1002/mnfr.200700486. - DOI - PubMed
    1. Cermak R., Durazzo A., Maiani G., Böhm V., Kammerer D.R., Carle R., Wiczkowski W., Piskula M.K., Galensa R. The influence of postharvest processing and storage of foodstuffs on the bioavailability of flavonoids and phenolic acids. Mol. Nutr. Food Res. 2009;53(Suppl. 2):S184–S193. doi: 10.1002/mnfr.200700444. - DOI - PubMed
    1. Falcone Ferreyra M.L., Rius S.P., Casati P. Flavonoids: Biosynthesis, biological functions, and biotechnological applications. Front. Plant. Sci. 2012;3:222. doi: 10.3389/fpls.2012.00222. - DOI - PMC - PubMed
    1. Kabera J.N., Semana E., Mussa A.R., He X. Plant secondary metabolites: Biosynthesis, classification, function and pharmacological properties. J. Pharm. Pharmacol. 2014;2:377–392.
    1. Patel D., Shukla S., Gupta S. Apigenin and cancer chemoprevention: Progress, potential and promise (review) Int. J. Oncol. 2007;30:233–245. doi: 10.3892/ijo.30.1.233. - DOI - PubMed